My bookmarksSign up free
Source

Commission Implementing Decision (EU) 2023/1155 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Rapid Pro referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2023) 3666) (Text with EEA relevance)

Commission Implementing Decision (EU) 2023/1155 of 9 June 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product Rapid Pro referred by France in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2023) 3666) (Text with EEA relevance)

Implementing Decision (EU) 2023/1155 · Decision · 2 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The biocidal product identified by the asset numbers AT-0016213-0000, BE-0011978-0000, CH-0016234-0000, DE-0015430-0000, DK-0012634-0000, ES-0014035-0000, FR-0012648-0000, IE-0014481-0000, IT-0014977-0000, LU-0012652-0000, LT-0018189-0000, NL-0016288-0000, NO-0015333-0000, PT-0020295-0000 in the Register for Biocidal Products (‘the biocidal product’) does not fully meet the conditions laid down in Article 19(1), point (b)(iii), of Regulation (EU) No 528/2012. The biocidal product may only be authorised in accordance with Article 19(5) of Regulation (EU) No 528/2012 in Member States who consider that not authorising it would result in disproportionate negative impacts for society when compared to the risks to human health, animal health or the environment arising from the use of the biocidal product under the conditions laid down in the authorisation. The use of the biocidal product shall be subject to appropriate risk mitigation measures, as referred to in Article 19(5) of Regulation (EU) No 528/2012, which shall be adopted in each Member State based on the particular circumstances and available evidence of the occurrence of primary and secondary poisoning incidents in that Member State.

Other acts of the same type
Commission Implementing Decision (EU) 2026/1129 of 22 May 2026 postponing the expiry date of the approval of IPBC for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCouncil Decision (CFSP) 2026/1152 of 22 May 2026 extending the mandate of the European Union Special Representative for the Middle East Peace Process and amending Decision (CFSP) 2025/976Council Decision (CFSP) 2026/1153 of 22 May 2026 on an assistance measure under the European Peace Facility to support the Albanian Armed ForcesCouncil Decision (CFSP) 2026/1157 of 22 May 2026 amending Decision (CFSP) 2023/1532 concerning restrictive measures in view of Iran’s military support to Russia’s war of aggression against Ukraine and to armed groups and entities in the Middle East and the Red Sea regionCommission Implementing Decision (EU) 2026/1162 of 21 May 2026 amending Implementing Decision (EU) 2021/1803 setting out the provisional amounts allocated to each Member State from the resources of the Brexit Adjustment Reserve and the minimum amount of support to local and regional coastal communities (notified under document C(2026) 1768)Commission Implementing Decision (EU) 2026/1089 of 20 May 2026 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Decision (EU) 2026/1145 of 20 May 2026 amending the Annexes to Implementing Decision (EU) 2025/1582 concerning certain emergency measures relating to infection with lumpy skin disease virus in Italy (notified under document C(2026) 3474)Commission Implementing Decision (EU) 2026/1141 of 19 May 2026 on the request for registration, pursuant to Regulation (EU) 2019/788 of the European Parliament and of the Council, of the European citizens’ initiative entitled Rights for Nature: Empower Citizens to Represent and Protect EcosystemsCommission Implementing Decision (EU) 2026/1142 of 19 May 2026 on the request for registration, pursuant to Regulation (EU) 2019/788 of the European Parliament and of the Council, of the European citizens’ initiative entitled Reconnecting nature through the creation of European biodiversity corridorsDecision (EU) 2026/1190 of the European Central Bank of 19 May 2026 amending Decision (EU) 2025/2419 on the approval of the volume of coin issuance in 2026 (ECB/2025/37) (ECB/2026/12)Council Decision of 18 May 2026 replacing an alternate member of the Advisory Committee on Safety and Health at Work for AustriaDecision of the Bureau of the European Parliament of 18 May 2026 amending the Rules on access to the European Parliament

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next